Overview
Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.
Indications & Related Conditions
Conditions associated via SNOMED clinical relationships
Administration & Protocol
Dosing, route, and treatment protocol
Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.
Monitoring & Follow-Up
Biomarkers relevant to this intervention via related conditions
Clinical Trials
54 trials linked to this intervention
Recent Trials
TRADE-Testosterone Replacement and Dutasteride Effectiveness
Testosterone Replacement in Older Men and Atherosclerosis Progression
Testosterone for Men With Insulin Treated Type 2 Diabetes
Effect of Androgel on Type 2 Diabetic Males With Hypogonadism
The Therapy of Nebido as Mono or in Combination With PDE-5 Inhibitors in Hypogonadal Patients With Erectile Dysfunction
Research Evidence
Published studies and systematic reviews
Research data from MEDLINE/PubMed
Benefits & Expected Outcomes
Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.
Risks & Side Effects
Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.
Related Symptoms
Symptoms associated with conditions this intervention addresses
No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.
Alternatives & Comparisons
Alternative treatments, comparison data, and clinical decision support are pending physician authorship.
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Do not start, stop, or change any treatment without consulting your healthcare provider.
Specialists
Providers who commonly manage this intervention
Internal Medicine — Endocrinology, Diabetes & Metabolism
NUCC 207RE0101XObstetrics & Gynecology
NUCC 207V00000XObstetrics & Gynecology — Reproductive Endocrinology
NUCC 207VE0102XUrology
NUCC 208800000XHealth Goals
Goals connected through associated conditions
Quick Facts
- Type
- Substance / Medication
- Fully Specified Name
- Choriogonadotropin alfa (substance)
- SNOMED CT
- 129494006
- UMLS CUI
- C0937609
Clinical Data
This intervention maps to 12 entities in the Ltrl knowledge graph.
Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.